At 15.1x earnings and 11.5x forward earnings, the market is pricing DKL as a modestly undervalued cash-flow vehicle, but not a growth compounder. The compression from current P/E to forward P/E suggests earnings normalization, especially with EPS at 10.5 versus next year’s estimate of $3.30, implying volatility in profitability. The Altman Z-Score of 1.2 signals balance sheet fragility and elevated financial stress risk, which materially offsets any valuation appeal. With a Piotroski F-Score of 3 and a PEG Forward not provided, this is not a clean GARP setup — it is a leveraged yield play with real downside risk if fundamentals deteriorate. The market is not obviously mispricing explosive growth; it is discounting risk.